Steven M. Safyer, President and CEO, Montefiore Medical Center, said, "Montefiore is honored to be a grant recipient of New York State's Empire Clinical Research Investigator Program. New York's support will expand the breadth of training for junior faculty clinical researchers to include comparative effectiveness research and support existing substantial efforts at Montefiore. We applaud New York for expanding research funding and look forward to continuing to work with the Department of Health to inform and improve clinical practice both locally and across New York State."
Thomas McGinn, M.D., chairman of medicine, North Shore-LIJ Health System said, "Training our best and brightest clinicians in patient-centered medical research and care, at all of our hospitals, is a priority of the health system. Promoting the development of clinician researchers while also providing seed funding for new federal center-type research projects is a win for everyone - doctors, patients and hospitals."
Mark Taubman, M.D., dean of the University of Rochester School of Medicine and Dentistry said, "Surgical care and medical-based procedures are one of the largest components of the U.S. health care system, with more than 230 million performed annually for various conditions including cancer, cardiovascular disease, and stroke. This project will support research by junior faculty and trainees in several departments and will focus on identifying variations in care and risk factors, eliminating complications, and developing cost-effective models for seamless care that can be replicated across New York State."
Robert D'Amico, M.D., Chairman, Department of Ophthalmology at Richmond University Medical Center, said, "Richmond University Medical Center's (RUMC) first-ever ECRIP award, for a translational eye research project, is the result of collaboration between RUMC and SUNY Downstate. This project utilizes the clinical strengths of RUMC with the cutting edge research performed at SUNY Downstate. Two ECRIP fellows will receive support to develop an artificial trabecular meshwork to treat glaucoma, a potentially blinding disease that is very prevalent in populations traditionally served by RUMC."
Margaret Paroski, M.D., chief medical officer of Kaleida Health said, "Kaleida Health is honored to have two of our abstracts receive funding. This essential funding will help to continue to train our physicians as clinical researchers with the goal of advancing bioscience in Buffalo and Western New York."
For more information on the ECRIP program visit: http://www.health.ny.gov/professionals/doctors/graduate_medical_educatio....
TNS 30FurigayJane-131015-4519090 30FurigayJane